These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 1376008)

  • 21. Immunohistochemical demonstration of H antigen, peanut agglutinin receptor, and Saphora japonica receptor expression in infant thymuses and thymic neoplasias.
    Wiley EL; Nosal JM; Freeman RG
    Am J Clin Pathol; 1990 Jan; 93(1):44-8. PubMed ID: 1688483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder.
    Vogel J; Oehr P; Maisey R; Adolphs HD
    Cancer Detect Prev; 1988; 11(3-6):389-96. PubMed ID: 2455597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas.
    Jautzke G; Altenaehr E
    Cancer; 1982 Nov; 50(10):2052-6. PubMed ID: 6751517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucin expression by transitional cell carcinomas of the bladder.
    Walsh MD; Hohn BG; Thong W; Devine PL; Gardiner RA; Samaratunga ML; McGuckin MA
    Br J Urol; 1994 Mar; 73(3):256-62. PubMed ID: 8162502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brenner tumor of the ovary: a comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder.
    Ordóñez NG; Mackay B
    Ultrastruct Pathol; 2000; 24(3):157-67. PubMed ID: 10914427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2.
    Heyderman E; Larkin SE; O'Donnell PJ; Haines AM; Warren PJ; Northeast A; Grant AG
    J Clin Pathol; 1990 Jun; 43(6):448-52. PubMed ID: 1696288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
    Jones HL; Delahunt B; Bethwaite PB; Thornton A
    Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
    Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
    Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical demonstration of epithelial membrane antigen (EMA), carcinoembryonic antigen (CEA), and keratin on mammary and extramammary Paget's disease.
    Mori O; Hachisuka H; Sasai Y
    Acta Histochem; 1989; 85(1):93-100. PubMed ID: 2469278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of carcinoembryonic antigen in tissue, serum and urine in patients with transitional cell carcinoma of the urinary bladder.
    Jakse G; Rauschmeier H; Rosmanith P; Hofstädter F
    Urol Int; 1983; 38(3):121-5. PubMed ID: 6868210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial antigens in carcinomas of the ovaries. Relation to histological classification.
    Jørgensen A; Nielsen K
    APMIS; 1994 Jul; 102(7):533-7. PubMed ID: 7522476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
    Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
    Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of epithelial membrane antigen in eccrine poroma.
    Takanashi M; Urabe A; Nakayama J; Hori Y
    Dermatologica; 1991; 183(3):187-90. PubMed ID: 1720746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of ABH antigens and CEA for the prognosis of urothelial tumors].
    Hofstädter F; Jakse G
    Wien Klin Wochenschr; 1982 Jul; 94(14):366-8. PubMed ID: 7147976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small cell carcinoma of the urinary bladder. A clinicopathological study of six cases.
    Lopez JI; Angulo JC; Flores N; Toledo JD
    Br J Urol; 1994 Jan; 73(1):43-9. PubMed ID: 7507782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microcystic adnexal carcinoma. An immunohistochemical comparison with other cutaneous appendage tumors.
    Wick MR; Cooper PH; Swanson PE; Kaye VN; Sun TT
    Arch Dermatol; 1990 Feb; 126(2):189-94. PubMed ID: 1689137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential value of antisera to epithelial membrane antigen in detecting early invasion in transitional cell carcinoma.
    Pocock RD; Ibrahim SK; Sloane JP; Ponder BA; Shearer RJ
    Br J Urol; 1983 Dec; 55(6):670-5. PubMed ID: 6652437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens.
    McKenney JK; Desai S; Cohen C; Amin MB
    Am J Surg Pathol; 2001 Aug; 25(8):1074-8. PubMed ID: 11474293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical distribution of epithelial membrane antigen in bladder carcinomas as detected with a monoclonal antibody.
    Asamoto M; Fukushima S; Oosumi H; Tatemoto Y; Mori M
    Urol Res; 1989; 17(5):273-7. PubMed ID: 2683314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.